A note before you read this: This reflects my personal experience and the stock’s fundamentals as of May 2021 — genuinely old given how quickly markets move, especially for a penny stock. It isn’t current investment advice. Check today’s price, financials, and recent news before making any decision, and consider speaking with a SEBI-registered financial advisor for personalized guidance.
Since the second wave of covid hit our country, I was thinking to buy some stock that will thrive in this period. And only stock trading high is pharma stocks. So, I searched for a few list of pharma stocks and decided to buy a stock that has moderately good fundamentals and cost me less, typically I was looking for good penny stocks. Gennex Laboratories Ltd was, at the time, a penny stock I thought had multibagger potential — though penny stocks are inherently high-risk and speculative, and hindsight is the only way to know whether that potential was realized.
Because of covid, most established pharma stocks were trading at high rates. Penny stocks were what was affordable for me at the time. I was looking for a long-term stock to hold and buy at a low price — with the honest acknowledgment that this kind of bet could go either way.
At the time this was written, the stock had traded from Rs 3 to Rs 13 depending on market conditions — a wide, volatile range typical of penny stocks.
At the time, Gennex Laboratories supplied bulk pharma ingredients to pharma manufacturers and intermediates, with manufacturing facilities across India serving domestic and international customers. The company had a market capitalization of around 50 crores, was showing year-on-year profit growth, and had an ROE of roughly 5%. Based on those fundamentals at the time, I bought around 100 shares.
The shareholding pattern at the time showed just two holder categories — public (over 70%) and promoters (around 22%) — with no foreign institutional investment.
I never followed up publicly on how this specific position ultimately performed — please don’t treat this post as evidence of an outcome. If you’re curious about this stock today, check its current fundamentals and price history directly rather than relying on this 2021 snapshot.
